Concepedia
Statistics
Publications
14
Citations
545
H-Index
13
Active since
2014
Affiliations
Leiden University Medical Center(Current)
Leiden University
ISA Pharmaceuticals (Netherlands)
Genmab (Netherlands)
Oncode Institute
Gijs G. Zom is an author at Leiden University Medical Center specializing in immunology, innate immunity, and vaccinology.
Publications per year
2014–2024
Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
Gijs G. Zom, Selina Khan, Cedrik M. Britten et al. · Cancer Immunology Research · 2014 · 97 citations · Full text
Medicine, Immunology, Oncology +17
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
Gijs G. Zom, Marian M. J. H. P. Willems, Selina Khan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 70 citations · Full text
Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer
Louise A. Koopman, Mikkel G. Terp, Gijs G. Zom et al. · JCI Insight · 2019 · 54 citations · Full text
Medicine, Oncology, Pharmacology +17
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
Gijs G. Zom, Marij J.P. Welters, Nikki M. Loof et al. · Oncotarget · 2016 · 50 citations · Full text
Life Sciences, Immunology, Oncology +17
Logic-gated antibody pairs that selectively act on cells co-expressing two antigens
Simone C. Oostindie, Derek A. Rinaldi, Gijs G. Zom et al. · Nature Biotechnology · 2022 · 45 citations · Full text
Pharmacy, Immunology, Molecular Biology +17
1–5 of 14